title: [Comparison of preventive effect of "new" and "old" antihypertensive agents].
abstract: BACKGROUND
  Until recently no morbidity-mortality study had examined the effects of newer drugs like angiotensin-converting enzyme inhibitors, calcium-antagonists and alpha-blockers compared to "old" but well-proven thiazide diuretics and beta-blockers in the treatment of essential hypertension.
  
  
  METHODS
  The prospective and randomized clinical trials CAPPP, STOP-2, NORDIL, INSIGHT and one arm of ALLHAT, with a total of approximately 58,000 middle-aged or elderly hypertensive patients have been assessed.
  
  
  RESULTS
  The primary outcome, composite cardiovascular (CV) death, cerebral stroke and myocardial infarction, in one study with heart failure, or composite fatal coronary heart disease and myocardial infarction, was equal in all trials.
  
  
  CONCLUSIONS
  According to current evidence, prevention of cardiovascular disease in hypertension is the same irrespective of the class of drug.
authors: Hjertemedisinsk avdeling, Hjerte-lunge-senteret, Ullevål sykehus, 0407 Oslo. sverrekj@ioks.uio.no
authors: S E
authors: SE
authors: Kjeldsen
authors: J O
authors: JO
authors: Syvertsen
authors: P
authors: P
authors: Lund-Johansen
authors: P
authors: P
authors: Hildebrandt
authors: L
authors: L
authors: Hansson
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control*; D003327:Coronary Disease / Q000401:mortality / Q000517:prevention & control*; D004232:Diuretics; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage
chemical_list: D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors